Last update of the site: October 7th, 2025
Wu Lili 1 et al. | Lipids in Health and Disease
Abstract Background Evidence linking urinary metabolites of volatile organic compounds (UMVOCs) to dyslipidemia remains limited and scarce. This research sought
Sen Nguyen Thi Thu 1 et al. | BMC Cardiovascular Disorders
Abstract Background The rs688 polymorphism in the LDLR gene has been linked to lipid profile alterations, yet its impact in
Liu Chengxing 1 et al. | Journal of Health, Population and Nutrition
Abstract Background Magnesium, an essential dietary trace element, plays a crucial role in numerous physiological processes, and its deficiency has
Daghistani Hussam 1 et al. | Lipids in Health and Disease
Abstract Long noncoding RNAs (lncRNAs) have emerged as critical regulators of lipid metabolism, playing pivotal roles in cholesterol biosynthesis, transport,
Francisco Martínez‐Mardones 1 et al. | British Journal of Clinical Pharmacology
Abstract Aims Cardiovascular diseases (CVD) are the primary cause of death in Chile. Pharmacist‐led medication review with follow‐up (MRF) has
Katzmann Julius L. et al. | Current Cardiology Reports
Abstract Purpose of Review Low-density lipoprotein cholesterol (LDL-C) is one major cause of cardiovascular disease (CVD). In this review, we
Tassew Worku Chekol 1 et al. | BMC Cardiovascular Disorders
Abstract Introduction Dyslipidemia and other CVD risk factors in cardiac patients can lead to accelerated atherosclerosis, morbidity, and significant
Daghistani Hussam 1 et al. | Lipids in Health and Disease
Abstract Long noncoding RNAs (lncRNAs) have emerged as critical regulators of lipid metabolism, playing pivotal roles in cholesterol biosynthesis, transport,
Yang Ningjing 1 et al. | Lipids in Health and Disease
Abstract Background Primary healthcare (PHC) plays a key role in hyperlipidemia (HL) management yet lacks adequate monitoring and feedback. This
